No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	talquetamab-tgvs Sensitive: A1 - Approval talquetamab-tgvs Sensitive : A1	talquetamab-tgvs Sensitive: A1 - Approval talquetamab-tgvs Sensitive : A1
GPRC5D overexpression	Multiple Myeloma	GPRC5D overexpression	Multiple Myeloma	talquetamab-tgvs Sensitive: D – Preclinical talquetamab-tgvs Sensitive : D	talquetamab-tgvs Sensitive: D – Preclinical talquetamab-tgvs Sensitive : D
GPRC5D expression	Multiple Myeloma	GPRC5D expression	Multiple Myeloma	JNJ-5322 Sensitive: D – Preclinical JNJ-5322 Sensitive : D	JNJ-5322 Sensitive: D – Preclinical JNJ-5322 Sensitive : D
TNFRSF17 expression	Multiple Myeloma	TNFRSF17 expression	Multiple Myeloma	JNJ-5322 Sensitive: D – Preclinical JNJ-5322 Sensitive : D	JNJ-5322 Sensitive: D – Preclinical JNJ-5322 Sensitive : D
TNFRSF17 expression + GPRC5D expression	Multiple Myeloma	TNFRSF17 expression + GPRC5D expression	Multiple Myeloma	JNJ-5322 Sensitive: D – Preclinical JNJ-5322 Sensitive : D	JNJ-5322 Sensitive: D – Preclinical JNJ-5322 Sensitive : D

GPRC5D inhibitor

Associations(5)